Vertex, Inc. shares have plunged over 60% YTD, but valuation is now compelling after a post-earnings dip. Learn more about VERX stock here.

One key figure, however, indicates otherwise as sales for Journavx were at $20 million for the period, coming up $3 million ...

The stock, which is down more than 61% in 2025, sold off after reporting a Q3 EPS beat missing on revenue expectations.

The Green Bay Packers have real questions at cornerback right now. The team invested heavily in free agent Nate Hobbs during the offseason. Thus far, Hobbs has struggled with injuries and inconsistent ...

Almost all UNHCR vacancies are advertised on the UNHCR online recruitment platform, and new opportunities are regularly added. Please note that applications are only accepted via the UNHCR online ...

Former Liverpool midfielder Jamie Redknapp: "When you ask what is going wrong with Liverpool, there are so many things. It's not just the defence, it's not just the midfield or the forwards, it is so ...

Frustrated by the price of a lifesaving cystic fibrosis treatment sold by Vertex Pharmaceuticals, a group of families is working with a generic manufacturer to revive a buyer’s club and distribute the ...

A step-by-step guide to help you fill out a W-4 IRS Form W-4 dictates how much money is withheld from your gross pay for taxes. Step 1 requires you to input personal details while Step 2 is required ...

Vertex stock dipped Tuesday on a mixed third-quarter report, with the lion's share of its sales beat coming from its older CF ...

Vertex Pharmaceuticals’ third quarter was marked by steady double-digit revenue growth, yet the market responded negatively ...